infohep
  • Menu
  • Search
  • Home
  • News
  • About hepatitis
  • Services
  • Countries
  • About us
  • Twitter
  • Facebook
  • RSS
  • Home
  • News
  • All the news

All the news

Showing 10 of 2,029 articles

Get an RSS feed of these articles

  • All news
  • infohep news
  • Editors' picks from other sources
  • Screening and testing policy

    67 homeless people in Merseyside now on HIV and Hepatitis C treatment plans

    ITV News / 18 August 2020

  • Coronavirus

    DCGI Rejects Mylan’s Request to Waive Phase 3 Trials for COVID-19 Drug

    Science Wire / 11 August 2020

  • Access to medicines & diagnostics

    South Africa: Breakthrough hepatitis C medicines remain in regulatory limbo

    Daily Maverick / 04 August 2020

  • Epidemiology

    A hard journey to a future free of hepatitis in Africa

    The Conversation / 04 August 2020

  • Hepatitis C elimination

    Scotland: NHS Tayside claims it has 'effectively eliminated' hepatitis C

    BBC Scotland / 28 July 2020

  • Finance, funding & health economics

    Developing an HCV Investment Case for Punjab (India)

    World Hepatitis Alliance / 28 July 2020

  • Coronavirus

    Care of Patients with Liver Disease during the COVID-19 Pandemic

    EASL / 27 July 2020

  • Coronavirus

    COVID-19 Toolkit for liver patient associations

    EASL / 27 July 2020

  • NAFLD

    Diabetes More Than Doubles Risk of Advanced Liver Disease

    HepMag / 27 July 2020

  • NAFLD

    Women Suffer Less NAFLD but More Advanced Fibrosis

    Medscape (requires free registration) / 27 July 2020

← Prev1...23456...203Next →
Other pages in this section
  • Latest news
  • All the news
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C
    • Hepatitis D
    • Hepatitis E
    • Coronavirus
    • NAFLD
    • Treatment for hepatocellular carcinoma
    • Transmission, epidemiology and prevention
    • Health services, policy and advocacy
    • Social issues
  • Conference news
  • Noticeboard
  • Email bulletins
  • News feeds

  • Contact us
  • Terms and conditions
  • Accessibility
  • Privacy and cookies

Latest hepatitis news

Sign-up for our monthly email bulletin Follow us on Twitter Find us on Facebook

The information on this website is intended to support, rather than replace, consultation with a healthcare professional.

©NAM Publications 2017. All rights reserved. We are not responsible for the content of external websites.

We are grateful to Abbvie, Janssen, Merck and Gilead for funding infohep.org. Our funders have had no editorial control over the site’s content.

infohep

Latest treatment news and information for patient advocates and people working in hepatitis in Europe.

NAM working with the World Hepatitis Alliance and the European Liver Patients Association

www.infohep.org/page//about-us/Find-out-about-NAM/page/2626330//   www.worldhepatitisalliance.org   www.elpa-info.org